Jim Cramer’s ‘Ignore the Chatter’ Guide: 10 Stocks to Buy Today

3. Eli Lilly and Company (NYSE:LLY)

Number of Hedge Fund Investors: 109

Cramer was nothing short of praises for the exceptional performance of Eli Lilly and Company (NYSE:LLY) stock, which has jumped by more than 50% in the year to date. The success of its GLP-1 drugs for diabetes and obesity was a major contributor to its strong financial results, leading the company to raise its full-year guidance.

The ‘Mad Money’ host considers Eli Lilly and Company (NYSE:LLY) a “best of breed” stock with strong prospects. BMO Capital rates Eli Lilly and Company (NYSE:LLY) a “Buy” with a $1,101 price target, citing strong potential in its diabetes and obesity treatment pipeline.